Hepatitis Drug Development Pipeline Review, 2017

“The Report Hepatitis Drug Development Pipeline Review, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz

About Hepatitis Drug Development Market

This report provides an overview of the hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hepatitis A, B, C and D, and features dormant and discontinued projects.

Hepatitis is a contagious viral infection affecting the liver, which may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting. The predisposing factors of hepatitis typically include dialysis, organ transplant and blood transfusion and the offspring of an infected mother also has high chances of contracting the disease.

Owing to differences in prevalence, hepatitis A and D have far smaller pipelines than hepatitis B and C; the size of these pipelines ranges from seven products in hepatitis A to 182 in hepatitis B and 199 in hepatitis C. Many of the companies who are actively fielding products in the larger two hepatitis subtypes are simultaneously developing products for both. While in hepatitis A, B and D, viral surface antigens and interferons are commonly targeted, a far wider range of proteins, including non-structural proteins, are the most common targets in hepatitis C.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1277496

Scope

– Which companies are the most active within the pipeline for hepatitis therapeutics?

– Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?

– To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?

– What are the most important R&D milestones and data publications to have happened in the field of hepatitis?

Reasons to buy

– Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication

– Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each

– Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these

– Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Contents

GBI Research Report Guidance 2

Executive Summary 3

Table of Contents 4

List of Tables 6

List of Figures 11

Introduction 12

Hepatitis Report Coverage 12

Hepatitis A – Overview 12

Hepatitis B – Overview 12

Hepatitis C – Overview 12

Hepatitis D – Overview 12

Therapeutics Development 13

Hepatitis A 13

Hepatitis B 17

Hepatitis C 30

Hepatitis D 43

Therapeutics Assessment 46

Hepatitis A 46

Hepatitis B 48

Hepatitis C 56

Hepatitis D 65

Companies Involved in Therapeutics Development 72

Hepatitis A 72

Hepatitis B 74

Hepatitis C 116

Hepatitis D 151

View Sample PDF @ https://www.marketresearchreports.biz/reports/1277496/hepatitis-drug-development-pipeline-review-2017-market-research-reports.pdf

Dormant Projects 155

Hepatitis A 155

Hepatitis B 155

Hepatitis C 159

Hepatitis D 169

Discontinued Products 170

Hepatitis B 170

Hepatitis C 170

Hepatitis D 173

Product Development Milestones 174

Hepatitis B 174

Hepatitis C 182

Hepatitis D 196

Appendix 208

Methodology 208

Coverage 208

Secondary Research 208

Primary Research 208

Expert Panel Validation 208

Contact Us 208

Disclaimer 209

List of Tables

Number of Products under Development for Hepatitis A 13

Number of Products under Development by Companies, Hepatitis A 14

Number of Products under Development by Universities/Institutes, Hepatitis A 15

Products under Development by Companies, Hepatitis A 16

Products under Development by Universities/Institutes, Hepatitis A 16

Number of Products under Development for Hepatitis B 17

Number of Products under Development by Companies, Hepatitis B 19

Number of Products under Development by Universities/Institutes, Hepatitis B 22

Products under Development by Companies, Hepatitis B 23

Products under Development by Universities/Institutes, Hepatitis B 29

Number of Products under Development for Hepatitis C 30

Number of Products under Development by Companies, Hepatitis C 32

Number of Products under Development by Universities/Institutes, Hepatitis C 35

Products under Development by Companies, Hepatitis C 36

Products under Development by Universities/Institutes, Hepatitis C 41

Number of Products under Development for Hepatitis D 43

Number of Products under Development by Companies, Hepatitis D 44

Number of Products under Development by Universities/Institutes, Hepatitis D 45

Products under Development by Companies, Hepatitis D 45

Products under Development by Universities/Institutes, Hepatitis D 45

Number of Products by Stage and Target, Hepatitis A 46

Number of Products by Stage and Molecule Type, Hepatitis A 47

Number of Products by Stage and Target, Hepatitis B 49

Number of Products by Stage and Mechanism of Action, Hepatitis B 51

Number of Products by Stage and Route of Administration, Hepatitis B 53

Number of Products by Stage and Molecule Type, Hepatitis B 55

Number of Products by Stage and Target, Hepatitis C 57

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1277496

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: